AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,296 | +194.7% | 57,149 | +106.3% | 0.00% | – |
| Q3 2022 | $32,000 | +255.6% | 27,704 | +95.7% | 0.00% | – |
| Q2 2022 | $9,000 | -92.9% | 14,159 | -70.7% | 0.00% | – |
| Q1 2022 | $126,000 | -43.5% | 48,312 | -15.7% | 0.00% | – |
| Q4 2021 | $223,000 | -30.1% | 57,307 | -21.7% | 0.00% | – |
| Q3 2021 | $319,000 | +18.1% | 73,165 | +7.5% | 0.00% | – |
| Q2 2021 | $270,000 | +11.1% | 68,030 | +45.3% | 0.00% | – |
| Q1 2021 | $243,000 | -11.3% | 46,826 | -8.5% | 0.00% | – |
| Q4 2020 | $274,000 | -29.7% | 51,167 | -36.3% | 0.00% | – |
| Q3 2020 | $390,000 | +306.2% | 80,327 | +304.6% | 0.00% | – |
| Q2 2020 | $96,000 | -65.8% | 19,851 | -58.9% | 0.00% | – |
| Q4 2019 | $281,000 | +778.1% | 48,336 | +373.5% | 0.00% | – |
| Q3 2019 | $32,000 | -88.5% | 10,209 | -74.6% | 0.00% | – |
| Q1 2019 | $278,000 | +110.6% | 40,160 | +92.2% | 0.00% | – |
| Q4 2018 | $132,000 | -64.9% | 20,895 | -2.6% | 0.00% | – |
| Q3 2018 | $376,000 | – | 21,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $55,906,000 | 83.77% |
| Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.61% |
| Oak Grove Capital LLC | 70,400 | $342,000 | 0.21% |
| Perceptive Advisors | 1,750,000 | $8,505,000 | 0.14% |
| WEDBUSH SECURITIES INC | 136,923 | $665,000 | 0.06% |
| Squarepoint Ops LLC | 193,856 | $942,000 | 0.02% |
| CWA Asset Management Group, LLC | 10,750 | $52,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,500 | $391,000 | 0.01% |
| Virtu Financial LLC | 10,933 | $53,000 | 0.01% |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | 40,512 | $196,000 | 0.01% |